ID   RN5A_MOUSE              Reviewed;         735 AA.
AC   Q05921; Q9ERU7;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   11-FEB-2002, sequence version 2.
DT   07-APR-2021, entry version 176.
DE   RecName: Full=2-5A-dependent ribonuclease;
DE            Short=2-5A-dependent RNase;
DE            EC=3.1.26.-;
DE   AltName: Full=Ribonuclease 4;
DE   AltName: Full=Ribonuclease L;
DE            Short=RNase L;
GN   Name=Rnasel; Synonyms=Rns4;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=C3H/An; TISSUE=Adipose tissue;
RX   PubMed=11063255; DOI=10.1007/s003350010194;
RA   Zhou A., Nie H., Silverman R.H.;
RT   "Analysis and origins of the human and mouse RNase L genes: mediators of
RT   interferon action.";
RL   Mamm. Genome 11:989-992(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-679.
RX   PubMed=7680958; DOI=10.1016/0092-8674(93)90403-d;
RA   Zhou A., Hassel B.A., Silverman R.H.;
RT   "Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator
RT   of interferon action.";
RL   Cell 72:753-765(1993).
RN   [3]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=11585831; DOI=10.1074/jbc.m107482200;
RA   Le Roy F., Bisbal C., Silhol M., Martinand C., Lebleu B., Salehzada T.;
RT   "The 2-5A/RNase L/RNase L inhibitor (RNI) pathway regulates mitochondrial
RT   mRNAs stability in interferon alpha-treated H9 cells.";
RL   J. Biol. Chem. 276:48473-48482(2001).
RN   [4]
RP   ERRATUM OF PUBMED:11585831.
RA   Le Roy F., Bisbal C., Silhol M., Martinand C., Lebleu B., Salehzada T.;
RL   J. Biol. Chem. 277:13354-13354(2002).
RN   [5]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Spleen;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   INTERACTION WITH TMEV LEADER PROTEIN (MICROBIAL INFECTION).
RX   PubMed=23825954; DOI=10.1371/journal.ppat.1003474;
RA   Sorgeloos F., Jha B.K., Silverman R.H., Michiels T.;
RT   "Evasion of Antiviral Innate Immunity by Theiler's Virus L* Protein through
RT   Direct Inhibition of RNase L.";
RL   PLoS Pathog. 9:E1003474-E1003474(2013).
RN   [7]
RP   INTERACTION WITH TMEV LEADER PROTEIN (MICROBIAL INFECTION).
RX   PubMed=29652922; DOI=10.1371/journal.ppat.1006989;
RA   Drappier M., Jha B.K., Stone S., Elliott R., Zhang R., Vertommen D.,
RA   Weiss S.R., Silverman R.H., Michiels T.;
RT   "A novel mechanism of RNase L inhibition: Theiler's virus L* protein
RT   prevents 2-5A from binding to RNase L.";
RL   PLoS Pathog. 14:E1006989-E1006989(2018).
CC   -!- FUNCTION: Endoribonuclease that functions in the interferon (IFN)
CC       antiviral response. In INF treated and virus infected cells, RNASEL
CC       probably mediates its antiviral effects through a combination of direct
CC       cleavage of single-stranded viral RNAs, inhibition of protein synthesis
CC       through the degradation of rRNA, induction of apoptosis, and induction
CC       of other antiviral genes. RNASEL mediated apoptosis is the result of a
CC       JNK-dependent stress-response pathway leading to cytochrome c release
CC       from mitochondria and caspase-dependent apoptosis. Therefore,
CC       activation of RNASEL could lead to elimination of virus infected cells
CC       under some circumstances. In the crosstalk between autophagy and
CC       apoptosis proposed to induce autophagy as an early stress response to
CC       small double-stranded RNA and at later stages of prolonged stress to
CC       activate caspase-dependent proteolytic cleavage of BECN1 to terminate
CC       autophagy and promote apoptosis. Might play a central role in the
CC       regulation of mRNA turnover (By similarity). Cleaves 3' of UpNp dimers,
CC       with preference for UU and UA sequences, to sets of discrete products
CC       ranging from between 4 and 22 nucleotides in length (By similarity).
CC       {ECO:0000250|UniProtKB:Q05823, ECO:0000269|PubMed:11585831}.
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC       Note=Manganese or magnesium. Required for optimal RNA cleavage rates.;
CC   -!- ACTIVITY REGULATION: After binding to 2-5A (5'-phosphorylated 2',5'-
CC       linked oligoadenylates) the homodimerization and subsequent activation
CC       occurs. Inhibited by RNASEL inhibitor ABCE1/RLI, a cytoplasmic member
CC       of the ATP-binding cassette (ABC) transporter family (By similarity).
CC       {ECO:0000250}.
CC   -!- SUBUNIT: (Microbial infection) Interacts (via N-terminus) with TMEV
CC       leader protein; this interaction prevents RNASEL activation by its
CC       substrate 2'-5' oligoadenylates. {ECO:0000269|PubMed:23825954,
CC       ECO:0000269|PubMed:29652922}.
CC   -!- SUBUNIT: Monomer (inactive form) or homodimer. Interacts with ABCE1;
CC       this interaction inhibits the RNASEL (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11585831}.
CC       Mitochondrion {ECO:0000269|PubMed:11585831}.
CC   -!- TISSUE SPECIFICITY: Expressed in spleen, thymus, lung, testis, kidney,
CC       liver and heart.
CC   -!- INDUCTION: By interferons. Virus replication in higher vertebrates is
CC       restrained by IFNs that cause cells to transcribe genes encoding
CC       antiviral proteins, such as 2'-5' oligoadenylate synthetases (OASs).
CC       oligoadenylate synthetase is stimulated by dsRNA to produce 5'-
CC       phosphorylated, 2'-5'-linked oligoadenylates (2-5A), whose function is
CC       to activate RNASEL.
CC   -!- DOMAIN: The nine ankyrin repeats also called 2-5A sensor constitute the
CC       N-terminus 2-5A binding domain.
CC   -!- DOMAIN: The protein kinase domain is predicted to be catalytically
CC       inactive. It allows the homodimerization.
CC   -!- DOMAIN: The ribonuclease domain is located in the C-terminus. A single
CC       active nuclease domain in a dimer is sufficient for ribonuclease
CC       activity.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF281045; AAG33708.1; -; mRNA.
DR   EMBL; L10382; AAA37117.1; -; Genomic_DNA.
DR   CCDS; CCDS15377.1; -.
DR   PIR; B45771; B45771.
DR   RefSeq; NP_036012.1; NM_011882.2.
DR   RefSeq; XP_006529590.1; XM_006529527.3.
DR   RefSeq; XP_006529591.1; XM_006529528.3.
DR   RefSeq; XP_006529593.1; XM_006529530.2.
DR   RefSeq; XP_011246295.1; XM_011247993.2.
DR   SMR; Q05921; -.
DR   STRING; 10090.ENSMUSP00000083385; -.
DR   BindingDB; Q05921; -.
DR   ChEMBL; CHEMBL2687; -.
DR   iPTMnet; Q05921; -.
DR   PhosphoSitePlus; Q05921; -.
DR   EPD; Q05921; -.
DR   MaxQB; Q05921; -.
DR   PaxDb; Q05921; -.
DR   PRIDE; Q05921; -.
DR   ProteomicsDB; 300452; -.
DR   Antibodypedia; 1127; 209 antibodies.
DR   Ensembl; ENSMUST00000086209; ENSMUSP00000083385; ENSMUSG00000066800.
DR   GeneID; 24014; -.
DR   KEGG; mmu:24014; -.
DR   UCSC; uc007daf.1; mouse.
DR   CTD; 6041; -.
DR   MGI; MGI:1098272; Rnasel.
DR   eggNOG; KOG1027; Eukaryota.
DR   eggNOG; KOG4177; Eukaryota.
DR   GeneTree; ENSGT00940000161114; -.
DR   InParanoid; Q05921; -.
DR   OrthoDB; 222916at2759; -.
DR   PhylomeDB; Q05921; -.
DR   TreeFam; TF344032; -.
DR   Reactome; R-MMU-8983711; OAS antiviral response.
DR   Reactome; R-MMU-909733; Interferon alpha/beta signaling.
DR   BioGRID-ORCS; 24014; 2 hits in 52 CRISPR screens.
DR   PRO; PR:Q05921; -.
DR   Proteomes; UP000000589; Chromosome 1.
DR   RNAct; Q05921; protein.
DR   Bgee; ENSMUSG00000066800; Expressed in blood and 238 other tissues.
DR   Genevisible; Q05921; MM.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0016363; C:nuclear matrix; ISO:MGI.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004519; F:endonuclease activity; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; ISO:MGI.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IEA:InterPro.
DR   GO; GO:0004540; F:ribonuclease activity; ISO:MGI.
DR   GO; GO:0043021; F:ribonucleoprotein complex binding; IDA:MGI.
DR   GO; GO:0003723; F:RNA binding; ISO:MGI.
DR   GO; GO:0019843; F:rRNA binding; ISO:MGI.
DR   GO; GO:0051607; P:defense response to virus; ISO:MGI.
DR   GO; GO:0045444; P:fat cell differentiation; IMP:MGI.
DR   GO; GO:0006397; P:mRNA processing; IEA:InterPro.
DR   GO; GO:0045071; P:negative regulation of viral genome replication; ISO:MGI.
DR   GO; GO:0046326; P:positive regulation of glucose import; IMP:MGI.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISO:MGI.
DR   GO; GO:0043488; P:regulation of mRNA stability; IMP:MGI.
DR   GO; GO:0006396; P:RNA processing; IBA:GO_Central.
DR   GO; GO:0006364; P:rRNA processing; ISO:MGI.
DR   CDD; cd10423; RNase_RNase-L; 1.
DR   Gene3D; 1.20.1440.180; -; 1.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR010513; KEN_dom.
DR   InterPro; IPR038357; KEN_sf.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR042745; RNase-L_RNase.
DR   Pfam; PF12796; Ank_2; 2.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF06479; Ribonuc_2-5A; 1.
DR   PRINTS; PR01415; ANKYRIN.
DR   SMART; SM00248; ANK; 8.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 7.
DR   PROSITE; PS51392; KEN; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; Antiviral defense; ATP-binding; Cytoplasm; Endonuclease;
KW   Hydrolase; Metal-binding; Mitochondrion; Nuclease; Nucleotide-binding;
KW   Reference proteome; Repeat; RNA-binding; Zinc; Zinc-finger.
FT   CHAIN           1..735
FT                   /note="2-5A-dependent ribonuclease"
FT                   /id="PRO_0000067052"
FT   REPEAT          24..53
FT                   /note="ANK 1"
FT   REPEAT          58..87
FT                   /note="ANK 2"
FT   REPEAT          91..120
FT                   /note="ANK 3"
FT   REPEAT          124..153
FT                   /note="ANK 4"
FT   REPEAT          167..197
FT                   /note="ANK 5"
FT   REPEAT          201..234
FT                   /note="ANK 6"
FT   REPEAT          238..268
FT                   /note="ANK 7"
FT   REPEAT          272..301
FT                   /note="ANK 8"
FT   REPEAT          303..328
FT                   /note="ANK 9"
FT   DOMAIN          364..584
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   DOMAIN          587..722
FT                   /note="KEN"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00725"
FT   ZN_FING         401..436
FT                   /note="C6-type"
FT                   /evidence="ECO:0000255"
FT   REGION          26..51
FT                   /note="Binding to TMEV Leader protein"
FT                   /evidence="ECO:0000269|PubMed:29652922"
FT   REGION          229..242
FT                   /note="2-5A binding (P-loop) 1"
FT   REGION          253..275
FT                   /note="2-5A binding (P-loop) 2"
SQ   SEQUENCE   735 AA;  83275 MW;  B6632F4A5B50F711 CRC64;
     METPDYNTPQ GGTPSAGSQR TVVEDDSSLI KAVQKGDVVR VQQLLEKGAD ANACEDTWGW
     TPLHNAVQAG RVDIVNLLLS HGADPHRRKK NGATPFIIAG IQGDVKLLEI LLSCGADVNE
     CDENGFTAFM EAAERGNAEA LRFLFAKGAN VNLRRQTTKD KRRLKQGGAT ALMSAAEKGH
     LEVLRILLND MKAEVDARDN MGRNALIRTL LNWDCENVEE ITSILIQHGA DVNVRGERGK
     TPLIAAVERK HTGLVQMLLS REGINIDARD NEGKTALLIA VDKQLKEIVQ LLLEKGADKC
     DDLVWIARRN HDYHLVKLLL PYVANPDTDP PAGDWSPHSS RWGTALKSLH SMTRPMIGKL
     KIFIHDDYKI AGTSEGAVYL GIYDNREVAV KVFRENSPRG CKEVSCLRDC GDHSNLVAFY
     GREDDKGCLY VCVSLCEWTL EEFLRLPREE PVENGEDKFA HSILLSIFEG VQKLHLHGYS
     HQDLQPQNIL IDSKKAVRLA DFDQSIRWMG ESQMVRRDLE DLGRLVLYVV MKGEIPFETL
     KTQNDEVLLT MSPDEETKDL IHCLFSPGEN VKNCLVDLLG HPFFWTWENR YRTLRNVGNE
     SDIKVRKCKS DLLRLLQHQT LEPPRSFDQW TSKIDKNVMD EMNHFYEKRK KNPYQDTVGD
     LLKFIRNIGE HINEEKKRGM KEILGDPSRY FQETFPDLVI YIYKKLKETE YRKHFPQPPP
     RLSVPEAVGP GGIQS
//
